These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 9667974

  • 1. N-Phenylamidines as selective inhibitors of human neuronal nitric oxide synthase: structure-activity studies and demonstration of in vivo activity.
    Collins JL, Shearer BG, Oplinger JA, Lee S, Garvey EP, Salter M, Duffy C, Burnette TC, Furfine ES.
    J Med Chem; 1998 Jul 16; 41(15):2858-71. PubMed ID: 9667974
    [Abstract] [Full Text] [Related]

  • 2. Aromatic reduced amide bond peptidomimetics as selective inhibitors of neuronal nitric oxide synthase.
    Hah JM, Martásek P, Roman LJ, Silverman RB.
    J Med Chem; 2003 Apr 24; 46(9):1661-9. PubMed ID: 12699384
    [Abstract] [Full Text] [Related]

  • 3. Selective inhibition of neuronal nitric oxide synthase by N omega-nitroarginine-and phenylalanine-containing dipeptides and dipeptide esters.
    Silverman RB, Huang H, Marletta MA, Martasek P.
    J Med Chem; 1997 Aug 29; 40(18):2813-7. PubMed ID: 9288162
    [Abstract] [Full Text] [Related]

  • 4. N(omega)-Nitroarginine-containing dipeptide amides. Potent and highly selective inhibitors of neuronal nitric oxide synthase.
    Huang H, Martasek P, Roman LJ, Masters BS, Silverman RB.
    J Med Chem; 1999 Aug 12; 42(16):3147-53. PubMed ID: 10447959
    [Abstract] [Full Text] [Related]

  • 5. Suppression of acute experimental colitis by a highly selective inducible nitric-oxide synthase inhibitor, N-[3-(aminomethyl)benzyl]acetamidine.
    Kankuri E, Vaali K, Knowles RG, Lähde M, Korpela R, Vapaatalo H, Moilanen E.
    J Pharmacol Exp Ther; 2001 Sep 12; 298(3):1128-32. PubMed ID: 11504810
    [Abstract] [Full Text] [Related]

  • 6. The novel imidazopyridine 2-[2-(4-methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine (BYK191023) is a highly selective inhibitor of the inducible nitric-oxide synthase.
    Strub A, Ulrich WR, Hesslinger C, Eltze M, Fuchss T, Strassner J, Strand S, Lehner MD, Boer R.
    Mol Pharmacol; 2006 Jan 12; 69(1):328-37. PubMed ID: 16223957
    [Abstract] [Full Text] [Related]

  • 7. Putative role of nitric oxide synthase isoforms in the changes of nitric oxide concentration in rat brain cortex and cerebellum following sevoflurane and isoflurane anaesthesia.
    Sjakste N, Sjakste J, Boucher JL, Baumane L, Sjakste T, Dzintare M, Meirena D, Sharipova J, Kalvinsh I.
    Eur J Pharmacol; 2005 Apr 25; 513(3):193-205. PubMed ID: 15862801
    [Abstract] [Full Text] [Related]

  • 8. The inhibitory potency and selectivity of arginine substrate site nitric-oxide synthase inhibitors is solely determined by their affinity toward the different isoenzymes.
    Boer R, Ulrich WR, Klein T, Mirau B, Haas S, Baur I.
    Mol Pharmacol; 2000 Nov 25; 58(5):1026-34. PubMed ID: 11040050
    [Abstract] [Full Text] [Related]

  • 9. Structural basis for dipeptide amide isoform-selective inhibition of neuronal nitric oxide synthase.
    Flinspach ML, Li H, Jamal J, Yang W, Huang H, Hah JM, Gómez-Vidal JA, Litzinger EA, Silverman RB, Poulos TL.
    Nat Struct Mol Biol; 2004 Jan 25; 11(1):54-9. PubMed ID: 14718923
    [Abstract] [Full Text] [Related]

  • 10. N-nitro-L-arginine and N-monomethyl-L-arginine exhibit a different pattern of inactivation toward the three nitric oxide synthases.
    Reif DW, McCreedy SA.
    Arch Biochem Biophys; 1995 Jun 20; 320(1):170-6. PubMed ID: 7540822
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of nitric oxide synthase isoforms by porphyrins.
    Wolff DJ, Naddelman RA, Lubeskie A, Saks DA.
    Arch Biochem Biophys; 1996 Sep 01; 333(1):27-34. PubMed ID: 8806750
    [Abstract] [Full Text] [Related]

  • 12. Substituted N-phenylisothioureas: potent inhibitors of human nitric oxide synthase with neuronal isoform selectivity.
    Shearer BG, Lee S, Oplinger JA, Frick LW, Garvey EP, Furfine ES.
    J Med Chem; 1997 Jun 06; 40(12):1901-5. PubMed ID: 9191968
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and evaluation of new sulfur-containing L-arginine-derived inhibitors of nitric oxide synthase.
    Ichimori K, Stuehr DJ, Atkinson RN, King SB.
    J Med Chem; 1999 May 20; 42(10):1842-8. PubMed ID: 10346937
    [Abstract] [Full Text] [Related]

  • 14. Relative contributions from neuronal and endothelial nitric oxide synthases to regional cerebral blood flow changes during forebrain ischemia in rats.
    Santizo R, Baughman VL, Pelligrino DA.
    Neuroreport; 2000 May 15; 11(7):1549-53. PubMed ID: 10841375
    [Abstract] [Full Text] [Related]

  • 15. Substituted 2-iminopiperidines as inhibitors of human nitric oxide synthase isoforms.
    Webber RK, Metz S, Moore WM, Connor JR, Currie MG, Fok KF, Hagen TJ, Hansen DW, Jerome GM, Manning PT, Pitzele BS, Toth MV, Trivedi M, Zupec ME, Tjoeng FS.
    J Med Chem; 1998 Jan 01; 41(1):96-101. PubMed ID: 9438025
    [Abstract] [Full Text] [Related]

  • 16. Nitroaromatic amino acids as inhibitors of neuronal nitric oxide synthase.
    Cowart M, Kowaluk EA, Daanen JF, Kohlhaas KL, Alexander KM, Wagenaar FL, Kerwin JF.
    J Med Chem; 1998 Jul 02; 41(14):2636-42. PubMed ID: 9651169
    [Abstract] [Full Text] [Related]

  • 17. Differential effects of selective and non-selective inhibition of nitric oxide synthase on the expression and activity of cyclooxygenase-2 during gastric ulcer healing.
    Guo JS, Cho CH, Wang JY, Koo MW.
    Eur J Pharmacol; 2006 May 01; 536(3):301-8. PubMed ID: 16600210
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of nitric oxide synthase by 1-(2-trifluoromethylphenyl) imidazole (TRIM) in vitro: antinociceptive and cardiovascular effects.
    Handy RL, Harb HL, Wallace P, Gaffen Z, Whitehead KJ, Moore PK.
    Br J Pharmacol; 1996 Sep 01; 119(2):423-31. PubMed ID: 8886430
    [Abstract] [Full Text] [Related]

  • 19. 2-Iminopyrrolidines as potent and selective inhibitors of human inducible nitric oxide synthase.
    Hagen TJ, Bergmanis AA, Kramer SW, Fok KF, Schmelzer AE, Pitzele BS, Swenton L, Jerome GM, Kornmeier CM, Moore WM, Branson LF, Connor JR, Manning PT, Currie MG, Hallinan EA.
    J Med Chem; 1998 Sep 10; 41(19):3675-83. PubMed ID: 9733492
    [Abstract] [Full Text] [Related]

  • 20. Potent and selective conformationally restricted neuronal nitric oxide synthase inhibitors.
    Gómez-Vidal JA, Martásek P, Roman LJ, Silverman RB.
    J Med Chem; 2004 Jan 29; 47(3):703-10. PubMed ID: 14736250
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.